-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Meridian Bioscience Inc quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q3 2010 to Q3 2022.
- Meridian Bioscience Inc Deferred Tax Assets, Net of Valuation Allowance for the quarter ending September 30, 2022 was $21.4M, a 5.22% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)